Treatment Overview
UroLift Tissue-Sparing BPH Treatment is a minimally invasive procedure designed to relieve urinary obstruction caused by Benign Prostatic Hyperplasia (BPH) while preserving prostate tissue. Instead of cutting, heating, or removing tissue, UroLift uses small permanent implants to lift enlarged prostate lobes away from the urethra. In Korea, this procedure is performed at advanced urology centers by experienced surgeons, providing a safe and effective outpatient solution for men seeking to maintain prostate integrity and sexual function.
Purpose & Benefits
The primary purpose of UroLift Tissue-Sparing Treatment is to improve urinary flow without compromising sexual or urinary function. Key benefits include:
- Minimally invasive, outpatient procedure
- No tissue removal or damage
- Immediate improvement in urinary flow and symptom relief
- Preservation of sexual and ejaculatory function
- Reduced risk of bleeding or infection compared to TURP or laser surgery
- Long-lasting relief with permanent implants
Ideal Candidates
Ideal candidates for UroLift Tissue-Sparing BPH Treatment include:
- Men with mild to moderate BPH symptoms
- Patients seeking a minimally invasive alternative to traditional surgery
- Individuals with prostate size under 100cc
- Patients who want to maintain sexual and ejaculatory function
- Men without significant median lobe obstruction or complex prostate anatomy
Possible Risks & Complications
Although UroLift is generally safe, potential risks may include:
- Temporary urinary urgency or frequency
- Mild hematuria (blood in urine) for a few days
- Burning or discomfort during urination
- Urinary tract infection
- Rare implant migration or need for retreatment
- Temporary urinary retention requiring short-term catheterization
Techniques & Technology Used
UroLift Tissue-Sparing BPH Treatment employs specialized implants and a delivery system:
- Delivery device inserted through the urethra
- Placement of small permanent implants to lift prostate lobes away from the urethra
- Real-time cystoscopic visualization ensures accurate implant positioning
- Implants remain permanently in place, maintaining urethral patency
- Procedure preserves all prostate tissue while relieving obstruction
Treatment Process in Korea
The typical UroLift Tissue-Sparing BPH process in Korea includes:
- Initial Consultation: Assessment of urinary symptoms, prostate size, and medical history
- Diagnostic Testing: Blood tests, urinalysis, PSA evaluation, and imaging as needed
- Procedure Preparation: Local or general anesthesia based on patient preference
- UroLift Procedure: Implant placement under cystoscopic guidance, usually completed within 60 minutes
- Post-Procedure Monitoring: Short observation period; most patients discharged the same day
Recovery & After-Care
Recovery after UroLift Tissue-Sparing Treatment is rapid and convenient:
- Mild urinary discomfort or urgency may occur for a few days
- Most patients resume normal activities within 24–48 hours
- Temporary catheterization may be required in rare cases
- Adequate hydration recommended to support urinary healing
- Follow-up visits monitor urinary improvement and implant position
Results & Longevity
UroLift Tissue-Sparing Treatment provides effective and durable relief:
- Immediate improvement in urinary flow
- Reduction in nocturia, urgency, and frequency
- Preservation of sexual and ejaculatory function
- Long-term studies show sustained improvement for over 5 years
- Additional procedures may be needed if BPH progresses or implants require adjustment
Why Korea Is a Top Destination
Korea is a preferred destination for UroLift Tissue-Sparing BPH Treatment due to:
- Advanced urology centers with highly skilled surgeons
- Access to the latest UroLift technology and permanent implants
- Affordable treatment costs compared to Western countries
- Comprehensive support for international patients, including consultation, translation, travel, and follow-up care
- High standards of patient safety, hygiene, and clinical monitoring
Cost Range
The cost of UroLift Tissue-Sparing BPH Treatment in Korea typically ranges from $6,500 to $10,500, depending on:
- Number of implants required and prostate anatomy
- Clinic and surgeon experience
- Inclusion of pre-procedure diagnostics, anesthesia, and follow-up care
Popular Clinics in Korea
Some of the top clinics offering UroLift Tissue-Sparing BPH Treatment in Korea include:
- Seoul Urology & Andrology Clinic
- JK Male Health Center, Seoul
- Korea Men’s Health Institute, Seoul
- VIP Male Clinic, Gangnam
- Dr. Kim’s Urology Clinic, Busan
